Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.570
+0.040 (1.13%)
At close: May 21, 2026, 4:00 PM EDT
3.590
+0.020 (0.56%)
After-hours: May 21, 2026, 7:41 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $372.65 million as of May 21, 2026. Its market cap has increased by 177.15% in one year.
Market Cap
372.65M
Enterprise Value
176.04M
1-Year Change
177.15%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $372.65M, an increase of 228.67%. That is a compound annual growth rate of 22.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 368.47M | 12.99% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 391.13M |
| Benitec Biopharma | 390.27M |
| Artiva Biotherapeutics | 388.22M |
| C4 Therapeutics | 387.84M |
| X4 Pharmaceuticals | 381.05M |
| Greenwich LifeSciences | 376.70M |
| Verastem | 375.22M |
| Vanda Pharmaceuticals | 373.44M |